Precipio

$2.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.47%) Today
-$0.02 (-0.94%) As of 5:23 PM EST after-hours

Why Robinhood?

You can buy or sell Precipio and other stocks, options, and ETFs commission-free!

About PRPO

Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT. The listed name for PRPO is Precipio, Inc. Common Stock.

CEO
Ilan Danieli
Employees
51
Headquarters
New Haven, Connecticut
Founded
1997
Market Cap
36.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
521.08K
High Today
$2.13
Low Today
$2.05
Open Price
$2.10
Volume
363.93K
52 Week High
$8.00
52 Week Low
$0.55

Collections

PRPO News

BenzingaNov 19

Precipio, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Precipio, Inc. (NASDAQ:PRPO) will be discussing their earnings results in their 2020 Third Quarter Earnings call

PRPO Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Expected Nov 16

You May Also Like